You have 9 free searches left this month | for more free features.

Secondary Attack Rate

Showing 51 - 75 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Left Atrial Appendage Closure as Secondary Prevention of Atrial

Recruiting
  • Non-valvular Atrial Fibrillation
  • Embolic Stroke
  • Transthoracic Echocardiography
  • Jinan, Shandong, China
  • +4 more
Dec 15, 2022

Headache Disorders, Primary, Headache Disorders, Secondary, Migraine Trial in Hangzhou

Not yet recruiting
  • Headache Disorders, Primary
  • +6 more
    • Hangzhou, Zhejiang, China
      Kaiming Liu
    Jun 9, 2022

    Balloon angiopLasty for Intracranial Atherosclerotic Minor

    Not yet recruiting
    • Ischemic Stroke
    • Submaximal balloon angioplasty
    • (no location specified)
    Aug 28, 2023

    Atrial Fibrillation Trial in Chicago (Parasym)

    Completed
    • Atrial Fibrillation
    • Parasym
    • Chicago, Illinois
      The University of Chicago
    Jul 11, 2022

    Asthma Attack, Asthma Trial in Singapore (Benralizumab 30 MG/ML [Fasenra], Placebos)

    Recruiting
    • Asthma Attack
    • Asthma
    • Benralizumab 30 MG/ML [Fasenra]
    • Placebos
    • Singapore, Foreign, Singapore
      Singapore General Hospital
    Jul 22, 2021

    Atrial Fibrillation, Diastolic Dysfunction, HFpEF - Heart Failure With Preserved Ejection Fraction Trial in Burlington (As

    Recruiting
    • Atrial Fibrillation
    • +2 more
    • As needed pharmacological rate control with beta-blocker (metoprolol tartrate, metoprolol succinate) or calcium channel blocker (diltiazem, verapamil)
    • Burlington, Vermont
      University of Vermont Medical Center
    Feb 28, 2023

    Uveitis Trial (Adalimumab plus different doses of oral glucocorticosteroid)

    Not yet recruiting
    • Uveitis
    • Adalimumab plus different doses of oral glucocorticosteroid
    • (no location specified)
    Nov 1, 2021

    Acute Demyelinating Syndrome Trial in France (Immediate Azathioprine (1st attack), Immediate Rituximab (1st attack), Standard of

    Not yet recruiting
    • Acute Demyelinating Syndrome
    • Immediate Azathioprine (1st attack)
    • +2 more
    • Besançon, France
    • +8 more
    Sep 14, 2022

    The COPD Attack Study

    Completed
    • Pulmonary Disease, Chronic Obstructive
    • Exacerbation COPD
    • It was an observational study
    • Kampala, Uganda
    • +1 more
    Mar 21, 2023

    Hereditary Angioedema Trial in Netherlands, United States (IONIS-PKK-LRx, Placebo)

    Completed
    • Hereditary Angioedema
    • Scottsdale, Arizona
    • +7 more
    Sep 15, 2022

    Ischemic Heart Disease, Acute Coronary Syndrome Trial in Bialystok

    Active, not recruiting
    • Ischemic Heart Disease
    • Acute Coronary Syndrome
      • Białystok, Poland
        Department of Invasive Cardiology, Medical University of Bialyst
      Mar 15, 2023

      Dementia, Cognitive Change, Stroke Trial (MIND diet intervention, General dietary advice)

      Not yet recruiting
      • Dementia
      • +4 more
      • MIND diet intervention
      • General dietary advice
      • (no location specified)
      Jun 17, 2023

      Influenza Trial in Baltimore, Durham (Influenza RG-A/Texas/71/2017 (H3N2) Challenge, Placebo)

      Recruiting
      • Influenza
      • Influenza RG-A/Texas/71/2017 (H3N2) Challenge
      • Placebo
      • Baltimore, Maryland
      • +1 more
      Aug 4, 2022

      Study on Hospitalization of Children With Bronchial Asthma

      Not yet recruiting
      • Asthma in Children
        • (no location specified)
        Mar 23, 2023

        Chronic Kidney Diseases, Cardiovascular Diseases, Bleeding Trial in Nottingham (Aspirin)

        Recruiting
        • Chronic Kidney Diseases
        • +2 more
        • Nottingham, United Kingdom
          Nottingham Digestive Diseases Centre
        Jan 3, 2022

        Secondary Acute Myeloid Leukemia Trial in Ann Arbor (Venetoclax, FLAG Protocol)

        Not yet recruiting
        • Secondary Acute Myeloid Leukemia
        • Ann Arbor, Michigan
          University of Michigan Rogel Cancer Center
        Mar 22, 2023

        Ischemic Stroke, TIA Trial in Italy (Aspirin, Clopidogrel, Ticagrelor)

        Recruiting
        • Ischemic Stroke
        • TIA
        • Avezzano, Abruzzo, Italy
        • +126 more
        Jul 29, 2022

        Exocrine Pancreatic Insufficiency, Acute Pancreatitis Trial in Helsinki

        Completed
        • Exocrine Pancreatic Insufficiency
        • Acute Pancreatitis
          • Helsinki, Finland
            Helsinki University Hospital
          Aug 15, 2022

          Paroxysmal Atrial Fibrillation Trial in Guangzhou (Pulse ablation catheter)

          Active, not recruiting
          • Paroxysmal Atrial Fibrillation
          • Pulse ablation catheter
          • Guangzhou, Guangdong, China
            the Second Affiliated Hospital of Sun Yat-sen University (Sun Ya
          Sep 10, 2023

          Myelofibrosis Trial in United States (Ruxolitinib)

          Recruiting
          • Myelofibrosis
          • Boston, Massachusetts
          • +4 more
          Oct 21, 2022

          Transient Ischemic Attack, Ischemic Stroke, Intracerebral Hemorrhage Trial in Philippines

          Recruiting
          • Transient Ischemic Attack
          • +4 more
            • Baguio City, Benguet, Philippines
            • +10 more
            Sep 9, 2021

            Testing VIRTUES Patient Care Sets in Cardiac Patients

            Not yet recruiting
            • Heart Diseases
            • +4 more
              • (no location specified)
              Jul 15, 2022

              Pulmonary Disease, Chronic Obstructive Trial in United States (Stiolto Respimat, ICS (Inhaled Corticosteroid) (Triple therapy),

              Completed
              • Pulmonary Disease, Chronic Obstructive
              • Stiolto Respimat
              • +3 more
              • Mobile, Alabama
              • +89 more
              May 24, 2022

              Respiratory Rate Trial in Arnhem (Instructions of breathing)

              Not yet recruiting
              • Respiratory Rate
              • Instructions of breathing
              • Arnhem, Netherlands
                Rijnstate Hospital
              Aug 15, 2023

              Secondary Antibody Deficiency Trial (Immunoglobulin replacement therapy (IGRT))

              Not yet recruiting
              • Secondary Antibody Deficiency
              • Immunoglobulin replacement therapy (IGRT)
              • (no location specified)
              Nov 4, 2022